Showing results (401-410 of 730) with videos related to
Sort By:
Pageof 73
The American Journal of Cardiology|June 25, 2017
Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial)Jeffrey B Washam, Anne S Hellkamp, Yuliya Lokhnygina, et al.American Heart Journal|September 7, 2016
Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trialRohan Shah, Anne Hellkamp, Yuliya Lokhnygina, et al.Journal of the American College of Cardiology|March 19, 2013
Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trialJonathan P Piccini, Susanna R Stevens, Yuliya Lokhnygina, et al.Stroke|April 26, 2014
Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trialKa Sing Lawrence Wong, Dai Yi Hu, Abraham Oomman, et al.Journal of the American Heart Association|November 5, 2019
Change in Blood Pressure Variability Among Treated Elderly Hypertensive Patients and Its Association With MortalityEnayet K Chowdhury, Mark R Nelson, Lindon M H Wing, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 27, 2005
Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirinYvonne C Gilleece, Rita E Browne, David Asboe, et al.American Journal of Hypertension|September 18, 2016
Prediction of 10-year Risk of Incident Heart Failure in Elderly Hypertensive Population: The ANBP2 StudyBerhe W Sahle, Alice J Owen, Lindon M H Wing, et al.Family Practice|April 17, 2020
Integration of absolute cardiovascular disease risk assessment into routine blood cholesterol testing at pathology servicesNiamh Chapman, Ricardo Fonseca, Leigh Murfett, et al.American Journal of Hypertension|September 21, 2014
Comparison of predictive performance of renal function estimation equations for all-cause and cardiovascular mortality in an elderly hypertensive populationEnayet K Chowdhury, Robyn G Langham, Alice Owen, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 29, 2022
Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke PreventionMukul Sharma, Carlos A Molina, Kazunori Toyoda, et al.Pageof 73